Journal
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT
Volume 21, Issue -, Pages 434-450Publisher
CELL PRESS
DOI: 10.1016/j.omtm.2021.03.021
Keywords
-
Categories
Funding
- National Institutes of Health [S10OD023527]
- Veterans Affairs Merit Award from the Department of Veterans Affairs [BX003671]
- National Institutes of Health, Bethesda, MD, USA [NS073653, GM085179, R56AG057469, R01NS109075]
- Penn AD Core Center grant [AG-10124-28]
Ask authors/readers for more resources
The study identified that decreased expression of the synaptic plasticity protein caveolin-1 may contribute to learning and memory deficits in Alzheimer's disease. Gene therapy targeted at PSAPP mice was able to improve learning and memory, neuronal structure, and maintain lipid raft profiles. This research suggests that gene therapy could be a potential option for treating Alzheimer's disease.
Alzheimer's disease (AD) is the most common form of neurodegeneration and cognitive dysfunction in the elderly. Identifyingmolecular signals that mitigate and reverse neurodegeneration in AD may be exploited therapeutically. Transgenic AD mice (PSAPP) exhibit learning and memory deficits at 9 and 11 months, respectively, with associated decreased expression of caveolin-1 (Cav-1), a membrane/lipid raft (MLR) scaffolding protein necessary for synaptic and neuroplasticity. Neuronal-targeted gene therapy using synapsin-Cav-1 cDNA (SynCav1) was delivered to the hippocampus of PSAPP mice at 3 months using adeno-associated virus serotype 9 (AAV9). Bilateral SynCav1 gene therapy was able to preserve MLRs profile, learning and memory, hippocampal dendritic arbor, synaptic ultrastructure, and axonal myelin content in 9- and 11-month PSAPP mice, independent of reducing toxic amyloid deposits and astrogliosis. Our data indicate that SynCav1 gene therapy may be an option for AD and potentially in other forms of neurodegeneration of unknown etiology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available